21.77
price down icon4.68%   -1.07
after-market アフターアワーズ: 21.55 -0.22 -1.01%
loading
前日終値:
$22.84
開ける:
$22.5
24時間の取引高:
643.69K
Relative Volume:
0.83
時価総額:
$1.31B
収益:
$439.00K
当期純損益:
$-105.64M
株価収益率:
-12.09
EPS:
-1.8
ネットキャッシュフロー:
$-60.70M
1週間 パフォーマンス:
-10.78%
1か月 パフォーマンス:
-5.39%
6か月 パフォーマンス:
-29.39%
1年 パフォーマンス:
-54.54%
1日の値動き範囲:
Value
$21.73
$22.86
1週間の範囲:
Value
$21.73
$24.54
52週間の値動き範囲:
Value
$21.73
$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Name
名前
Janux Therapeutics Inc
Name
セクター
Healthcare (1143)
Name
電話
(858) 751-4493
Name
住所
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
Name
職員
103
Name
Twitter
Name
次回の収益日
2024-08-06
Name
最新のSEC提出書
Name
JANX's Discussions on Twitter

JANX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JANX
Janux Therapeutics Inc
21.77 1.37B 439.00K -105.64M -60.70M -1.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-17 開始されました Barclays Overweight
2025-09-10 開始されました Stifel Buy
2025-09-10 開始されました Truist Buy
2025-09-04 開始されました Guggenheim Buy
2025-08-19 開始されました Piper Sandler Overweight
2025-07-11 開始されました Raymond James Outperform
2024-12-03 繰り返されました BTIG Research Buy
2024-12-03 繰り返されました H.C. Wainwright Buy
2024-11-22 開始されました Leerink Partners Outperform
2024-10-24 開始されました UBS Buy
2024-09-06 開始されました Stifel Buy
2024-05-30 開始されました Scotiabank Sector Perform
2024-03-21 開始されました BTIG Research Buy
2024-03-20 開始されました Cantor Fitzgerald Overweight
2023-04-06 開始されました Wedbush Outperform
2022-11-14 開始されました William Blair Outperform
すべてを表示

Janux Therapeutics Inc (JANX) 最新ニュース

pulisher
04:13 AM

Janux Therapeutics stock hits 52-week low at 21.97 USD - Investing.com

04:13 AM
pulisher
Sep 22, 2025

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated by Analysts at Barclays - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Top 5 Oncology Stocks to Watch According to Barclays By Investing.com - Investing.com Canada

Sep 22, 2025
pulisher
Sep 22, 2025

Janux Therapeutics (NASDAQ:JANX) Earns Overweight Rating from Analysts at Barclays - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Gap UpTime to Buy? - MarketBeat

Sep 22, 2025
pulisher
Sep 20, 2025

Institution Moves: Will Denison Mines Corp stock benefit from M A2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Janux Therapeutics Announces Departure of Chief Strategy Officer - The Globe and Mail

Sep 20, 2025
pulisher
Sep 20, 2025

Janux Therapeutics chief strategy officer departs in company-initiated move By Investing.com - Investing.com Nigeria

Sep 20, 2025
pulisher
Sep 19, 2025

Janux Therapeutics chief strategy officer departs in company-initiated move - Investing.com

Sep 19, 2025
pulisher
Sep 19, 2025

Big Money Moves: Is Janux Therapeutics Inc. stock a buy or sell2025 Analyst Calls & Technical Pattern Based Signals - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Janux Therapeutics, Inc. $JANX Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 19, 2025
pulisher
Sep 18, 2025

Momentum Shift: Is MGRM forming bullish engulfing patternsCEO Change & Free Expert Verified Stock Movement Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Closing: Can Janux Therapeutics Inc generate free cash flowPortfolio Return Report & Real-Time Stock Entry Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

US Market Wrap: Whats the fair value of Achieve Life Sciences Inc stockChart Signals & Smart Investment Allocation Tips - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Ideas: Is NetApp Inc subject to activist investor interestQuarterly Trade Review & Weekly Watchlist for Consistent Profits - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Investment Review: What is Janux Therapeutics Incs valuation compared to sectorOil Prices & Free Verified High Yield Trade Plans - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Momentum Shift: Should you avoid CBFV stock right nowMarket Performance Report & Risk Controlled Swing Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Barclays Initiates Coverage on JANX with Overweight Rating | JAN - GuruFocus

Sep 17, 2025
pulisher
Sep 17, 2025

Barclays Initiates Coverage of Janux Therapeutics (JANX) with Overweight Recommendation - Nasdaq

Sep 17, 2025
pulisher
Sep 17, 2025

Bernstein Initiates Janux Therapeutics at Overweight With $47 Price Target - MarketScreener

Sep 17, 2025
pulisher
Sep 16, 2025

Janux Therapeutics initiated with an Overweight at Barclays - TipRanks

Sep 16, 2025
pulisher
Sep 16, 2025

Highs Report: Is HCKT forming bullish engulfing patternsMarket Trend Report & Expert Verified Movement Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Swings: Should I hold or sell INNOVATE Corp. Equity Right now2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - khodrobank.com

Sep 16, 2025
pulisher
Sep 15, 2025

Market Fear: What is Janux Therapeutics Incs valuation compared to sectorWeekly Risk Summary & AI Powered Trade Plan Recommendations - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT - Yahoo Finance

Sep 15, 2025
pulisher
Sep 15, 2025

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Truist Financial - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

Woodline Partners LP Has $39.34 Million Holdings in Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Janux Therapeutics Inc. recovery potential after sell off2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Analyzing recovery setups for Janux Therapeutics Inc. investorsWeekly Risk Report & Fast Exit Strategy with Risk Control - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Statistical indicators supporting Janux Therapeutics Inc.’s strengthTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Visualizing Janux Therapeutics Inc. stock with heatmaps2025 Price Targets & Smart Money Movement Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

Comparing Janux Therapeutics Inc. in custom built stock radars2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

How hedge fund analytics apply to Janux Therapeutics Inc. stockExit Point & Weekly Momentum Picks - newser.com

Sep 14, 2025
pulisher
Sep 14, 2025

10 Best Up and Coming Stocks with Huge Upside Potential - Insider Monkey

Sep 14, 2025
pulisher
Sep 13, 2025

Institutional scanner results for Janux Therapeutics Inc.Market Risk Analysis & High Conviction Investment Ideas - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Short interest data insights for Janux Therapeutics Inc.Take Profit & Intraday High Probability Setup Alerts - Newser

Sep 13, 2025
pulisher
Sep 12, 2025

Cubist Systematic Strategies LLC Has $2.05 Million Position in Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

Bank of America Securities Remains a Buy on Janux Therapeutics Inc (JANX) - The Globe and Mail

Sep 12, 2025
pulisher
Sep 12, 2025

Possible Bearish Signals With Janux Therapeutics Insiders Disposing Stock - 富途牛牛

Sep 12, 2025
pulisher
Sep 12, 2025

Stifel Nicolaus Reaffirms “Buy” Rating for Janux Therapeutics (NASDAQ:JANX) - Defense World

Sep 12, 2025
pulisher
Sep 11, 2025

BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛

Sep 11, 2025
pulisher
Sep 11, 2025

Janux Therapeutics (NASDAQ:JANX) Coverage Initiated at Guggenheim - MarketBeat

Sep 11, 2025
pulisher
Sep 10, 2025

Alyeska Investment Group L.P. Purchases 63,762 Shares of Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 10, 2025
pulisher
Sep 10, 2025

Janux stock a new Buy at Truist on H2 catalysts (JANX:NASDAQ) - Seeking Alpha

Sep 10, 2025
pulisher
Sep 10, 2025

Truist Initiates Janux Therapeutics at Buy With $100 Price Target - MarketScreener

Sep 10, 2025
pulisher
Sep 10, 2025

Janux Therapeutics initiated with a Buy at Truist - TipRanks

Sep 10, 2025
pulisher
Sep 10, 2025

Buy Rating for Janux Therapeutics Inc: Promising Oncology Innovations and Strategic Advancements - TipRanks

Sep 10, 2025
pulisher
Sep 10, 2025

Janux Therapeutics resumed with a Buy at Stifel - TipRanks

Sep 10, 2025
pulisher
Sep 10, 2025

Stifel resumes Janux Therapeutics stock coverage with Buy rating By Investing.com - Investing.com Canada

Sep 10, 2025
pulisher
Sep 09, 2025

Walleye Capital LLC Makes New Investment in Janux Therapeutics, Inc. $JANX - MarketBeat

Sep 09, 2025
pulisher
Sep 09, 2025

Analysts Set Janux Therapeutics, Inc. (NASDAQ:JANX) PT at $86.90 - MarketBeat

Sep 09, 2025

Janux Therapeutics Inc (JANX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):